Treace Medical Concepts Inc (NAS:TMCI)
$ 7.9 -0.02 (-0.25%) Market Cap: 493.39 Mil Enterprise Value: 481.34 Mil PE Ratio: 0 PB Ratio: 4.69 GF Score: 51/100

Q3 2021 Treace Medical Concepts Inc Earnings Call Transcript

Nov 04, 2021 / 08:30PM GMT
Release Date Price: $24.23 (+0.79%)
Operator

Welcome to the Treace Medical Concepts Third Quarter 2021 Earnings Conference Call. My name is James, and I'll be your operator for today's call. (Operator Instructions)

I'd now like to turn the call over to [Sam Bensinger]. [Sam], you may begin.

Unidentified Company Representative

Thanks, James. Good afternoon, everyone, and welcome to our third quarter 2021 earnings call. Participating from the company today will be John Treace, Chief Executive Officer; and Mark Hair, Chief Financial Officer.

During the call, we will offer commentary on our commercial activity and review our third quarter financial results released after the close of the market today, after which we will host a question-and-answer session. The press release can be found in the Investor Relations section of our website at investors.treace.com. This call is being recorded and will be archived in the Investors section of our website.

Before we begin, we would like to remind you that it is our intent that all forward-looking statements made during today's call will be

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot